Capital Fund Management (CFM)
LXRX icon

Capital Fund Management (CFM)’s Lexicon Pharmaceuticals LXRX Stock Holding History

Capital Fund Management (CFM)’s Portfolio LXRX Stock Details LXRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-37,593
Closed -$520K – 1678
2016
Q4 		$520K Buy
+37,593
New +$603K ﹤0.01% 1252
2016
Q3 		– Sell
-19,700
Closed -$283K – 1697
2016
Q2 		$283K Buy
+19,700
New +$267K ﹤0.01% 1345

Other funds holding LXRX

AG
Artal Group Luxembourg $931M AUM 41.63% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
UL
Ulys LLC New York $25.4M AUM 201.03% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return
EAM
Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return
KCM
Kingdon Capital Management New York $976M AUM 66.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Capital Fund Management (CFM)'s LXRX Position: Q1 2017 in Review

Capital Fund Management (CFM) sold out of Lexicon Pharmaceuticals (LXRX) in Q1 2017, closing a stake of 37,593 shares — an estimated $520K sold.

Capital Fund Management (CFM) first reported a position in LXRX in Q2 2016 and held it in 2 quarters. The position peaked at $520K in Q4 2016. 137 funds tracked by Wall St. Rank hold LXRX as of Q1 2017.

  • Capital Fund Management (CFM) reported no remaining Lexicon Pharmaceuticals position as of Q1 2017 after selling out during the quarter.
  • Capital Fund Management (CFM) sold 37,593 Lexicon Pharmaceuticals shares in Q1 2017, an estimated $520K.
  • Capital Fund Management (CFM) first reported a position in Lexicon Pharmaceuticals in Q2 2016 and held it in 2 quarters.
  • Capital Fund Management (CFM)'s Lexicon Pharmaceuticals position peaked at $520K in Q4 2016.
  • 137 funds tracked by Wall St. Rank held Lexicon Pharmaceuticals as of Q1 2017.

Based on Capital Fund Management (CFM)'s 13F filing for Q1 2017, filed 3 May 2017.